Kalbe is a global health care company based in Jakarta, Indonesia, established in 1966. It operates as a supplier to the pharmaceutical industry through various business activities, including contract services, distribution, licensing, manufacturing, active pharmaceutical ingredients, and contract manufacturing (CMO/CDMO). Kalbe has developed a strong presence in international markets and has achieved a market capitalisation of US$ 5.5 billion. The company focuses on exploring opportunities in small molecules and biologics, as well as small volume parenteral and biologics CDMO services.

Services include:
- Biologics
- Small molecules out and in-licensing
- Small volume parenteral
- Contract Development and Manufacturing Organisation (CDMO) service
- Natural extract supply

Kalbe is committed to providing high-quality services and products to meet the evolving needs of the pharmaceutical industry. For more information, please visit kalbe.co.id.